TPST
Tempest Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.60
−3.86%Leverage
- Debt / equity
- -6.94x
- Net debt / equity
- -6.22x
- Debt / assets
- 0.78x
- Debt / EBITDA
- -0.19x
- Net debt / EBITDA
- -0.17x
Liquidity & coverage
- Current ratio
- 0.38x
- Quick ratio
- 0.38x
- Cash ratio
- 0.18x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- -$2.8M
Cash & dividend
- FCF / debt
- -2.74x
- Cash flow / debt
- -2.74x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026